Molecular staging of head and neck squamous carcinoma

Cancer and Metastasis Reviews

Volumn 15, Issue 1, 1996, Pages 3-10

  Brennan, Joseph A ^a,c   Sidransky, David ^b  

^a DAVID GRANT MEDICAL CENTER   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

^c Div of Hd and Neck Cancer Research   (United States)

Author keywords

genetics; molecular; mutations; p53; prognosis; staging

Indexed keywords

PROTEIN P53;

CANCER STAGING; HEAD AND NECK CARCINOMA; HUMAN; MOLECULAR GENETICS; MUTATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA;

ADULT; ANIMALS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICE; MIDDLE AGED; MOLECULAR BIOLOGY; NEOPLASM STAGING;

EID: 0030010946     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00049484     Document Type: Review

References (46)

1. Beahrs OH, Henson DE, Hutter RVP, Myers MH (eds): Manual for staging of cancer. 3rd ed. Philadelphia: J.B. Lippincott: 27-62, 1988
2. Robbins KT: Neck dissection classification and TNM staging of head and neck cancer. American Academy of Otolaryngology-Head and Neck Surgery Foundation: 1-29, 1991
3. Thawley SE, Panje WR: Comprehensive management of head and neck tumors. Philadelphia: W.B. Saunders Company: 780, 1987
4. Biller HF, Davis WH, Ogura JH: Delayed contralateral cervical metastases with laryngeal and laryngopharyngeal cancers. Laryngoscope 81: 1499, 1971
5. Ogura JH, Biller HF, Wette R: Elective neck dissection for pharyngeal and laryngeal cancers: an evaluation. Ann Otol Rhinol Laryngol 80: 646, 1971
6. Brennan JA, Mao L, Hruban RH et al.: Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Eng J Med 332: 429-435, 1995
7. Sidransky D, Von Eschenbach A, Tsai YC et al.: Identification of p53 gene mutations in bladder cancers and urine samples. Science 252: 706-709, 1991
8. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355: 846-847, 1992
9. Sidransky D, Tokino T, Hamilton SR et al.: Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102-105, 1992
10. Boyle J, Hakim J, Koch W et al.: The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res 53: 4477-4480, 1993
11. Brennan JA, Boyle JO, Koch WM et al.: Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Engl J Med 332: 712-717, 1995
12. Thomas S, Brennan J, Martel G et al.: Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Res 54: 3588-3593, 1994
13. Koch WM, Patel H, Brennan JA, Boyle JO, Sidransky D: Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg 121: 262-265, 1995
14. Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253: 49-53, 1991
15. Mao L, Hruban RH, Boyle HO, Tockman M, Sidransky D: Detection of oncogene mutations in sputum precedes the diagnosis of lung cancer. Cancer Res 54: 1634-1637, 1994
16. Nowel PC: The clonal evolution of tumor cell populations. Science 194: 23-28, 1976
17. Weinberg RA: Tumor Suppressor Genes. Science 254: 1138-1146, 1991
18. Friedman T: Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer 70: 1810-1817, 1992
19. Weinberg RA. The integration of molecular genetics into cancer management. Cancer 70: 1653-1658, 1992
20. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B: Clonal origin of bladder cancer. N Engl J Med 326: 737-740, 1992
21. Vogelstein B, Kinzler KW: Carcinogens leave fingerprints. Nature 355: 209-210, 1992
22. Harris CC, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329: 1318-1327, 1993
23. Hunter T: Cooperation between oncogenes. Cell 64: 249-270, 1991
24. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990
25. Peto R, Roe FJ, Lee PN, Levy L, Clack J: Cancer and ageing in mice and man. Br J Cancer 32: 411-426, 1975
26. Dix D: The role of aging in cancer incidence: an epidemiological study. J Gerontol 44: 10-18, 1989
27. Puisieux A, Lim S, Groopman J, Ozturk M: Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res 51: 6185-6189, 1991
28. Chung KY, Mukhopadhyay T, Kim J et al.: Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. Cancer Res 53: 1676-1683, 1993
29. Baker SJ, Preisinger AC, Jessup JM et al.: p53 mutations occur in combination with 17p allelic deletions as late events in colorecral tumorigenesis. Cancer Res 50: 7717-7722, 1990
30. Buchman GW, Schester DM, Raschtchas A: Rapid and efficient cloning of PCR products using the clone amp system. Focus 14: 41-45, 1992
31. Gusterson BA, Ramaswamy A, Warren W et al.: Expression of p53 in premalignant and malignant squamous epithelium. Oncogene 6: 1785-1789, 1991
32. Sakai E, Tsuchida N: Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene 7: 927 933, 1992
33. Melhem MF, Law JC, el-Ashmawy L et al.: Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol 146: 1170-1177, 1995
34. Xu L, Chen YT, Huvos AG, Zlotolow IM et al.: Overexpression of p53 protein in squamous cell carcinomas of the head and neck without apparent gene mutations. Diag Molec Pathol 3: 83-92, 1994
35. Fisher CJ, Gillett CE, Vojtesek B, Barnes DM, Millis RR: Problems with p53 immunohistochemical staining. Br J Cancer 69: 26-31, 1994
36. Wynford-Thomas D: p53 in tumour pathology: can we trust immunocytochemistry? J Pathol 166: 324-330, 1992
37. Brennan JA, Koch WM, Boyle JO et al.: Effect of p53 gene mutation on survival in head and neck squamous carcinoma. Submitted for publication, 1945
38. Yoo GH, Xu HJ, Brennan JA et al.: Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma. Cancer Res 54: 4603-4606, 1994
39. Nawroz H, van der Riet P, Koch W, Ruppert JM, Sidransky D: Allelotype of head and neck squamous cell carcinoma. Cancer Res 54: 1152-1155, 1494
40. Kowalski LP, Magrin J, Waksman G et al.: Supraomohoyoid neck dissection in the treatment of head and neck tumors. Otolaryngol Head Neck Surg 119: 958-963, 1993
41. Soo KC, Spiro RH, King W, Harvey W, Strong EW: Squamous carcinoma of the gums. Am J Surg 156: 281-285, 1988
42. Fielding LP, Fenoglio-Preiser CM, Freedman LS: The future of prognostic factors in outcome prediction for patients with cancer. Cancer 70: 2367-2377, 1992
43. Ghouri AF, Zamora RL, Harvey JE, Spitznagel EL, Sessions DG: Epidermoid carcinoma of the oral cavity and oropharynx: validity of the current AJCC staging system and new statistical tools for the prediction of subclinical neck disease. Otolaryngol Head Neck Surg 108: 225-232, 1993
44. Snow GB, Annyas AA, van Slooten FA, Bartelink H, Hart AA: Prognostic factors of neck node metastasis. Clin Otolaryngol 7: 185-192, 1982
45. Boyle JO, Mao L, Brennan JA et al.: Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 168: 424-432, 1994
46. Koch WM, Boule JO, Mao L, Hakim J, Hruban RH, Sidransky D: p53 gene mutations as markers of tumor spread in synchronous oral cancers. Arch Otolaryngol Head Neck Surg 120: 943-947, 1994